/PRNewswire/ The board of directors of BerGenBio ASA (the "Company") has today, subject to approval by the Annual General Meeting (the "AGM") on 22 May.
Monthly IPTp with dihydroartemisinin–piperaquine did not improve pregnancy outcomes,
and the addition of a single course of azithromycin did not enhance the effect of
monthly IPTp with dihydroartemisinin–piperaquine. Trials that combine sulfadoxine–pyrimethamine
and dihydroartemisinin–piperaquine for IPTp should be considered.
In a randomized controlled trial, Adrian Wells and colleagues test the effectiveness of adding self-help metacognitive therapy to cardiac rehabilitation in reducing anxiety and depression.